Antiplatelet and anticoagulation agents in acute coronary syndromes: What is the current status and what does the future hold?

Kurt Huber, Eric R. Bates, Marco Valgimigli, Lars Wallentin, Steen Dalby Kristensen, Jeffrey L. Anderson, Jose Luis Lopez Sendon, Marco Tubaro, Christopher B. Granger, Christoph Bode, Erik Magnus Ohman, Philippe Gabriel Steg
  • American Heart Journal, November 2014, Elsevier
  • DOI: 10.1016/j.ahj.2014.06.014
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Professor Philippe Gabriel STEG and Professor Marco Valgimigli